2020 News Releases Puma Biotechnology Releases Slides to be Presented at the J.P. Morgan Healthcare Conference
LOS ANGELES, Calif., Jan. 13, 2020 - Puma Biotechnology, Inc. (NASDAQ: PBYI), a
biopharmaceutical company, announced that its Chief Executive Officer and President, Alan H. Auerbach,
will be presenting at the 38 th Annual J.P. Morgan Healthcare Conference at 12:00 p.m. PST on
Wednesday, January 15, 2020. Mr. Auerbach will be providing a corporate update that will include, among
other things, the company’s preliminary estimate that it sold approximately 4,900 bottles of NERLYNX in
the United States in the fourth quarter of 2019. This preliminary estimate is subject to completion of the
Company’s customary closing and review procedures and could change based on that process. The slides to
be discussed during the presentation are currently available on the Investors section of Puma’s website at
https://investor.pumabiotechnology.com/sec-filings/all-filings/default.aspx. A live webcast of the
presentation will also be available on January 15, 2020, at www.pumabiotechnology.com. |
Puma Biotechnology, Inc. |
© 2024 Puma Biotechnology, Inc. | Privacy Policy | WA Privacy Policy | Terms of Service | Data Rights Request | Legal Notice | Site Map |